Searchable abstracts of presentations at key conferences in endocrinology

ea0090oc5.5 | Oral Communications 5: Adrenal and Cardiovascular Endocrinology 1 | ECE2023

Moving to liquid chromatography-tandem mass spectrometry to assess hypercortisolism states through dexamethasone suppression test: comparison with two routinely used immunoassays

Rotolo Laura , Tucci Lorenzo , Vicennati Valentina , Pagotto Uberto , Di Dalmazi Guido , Fanelli Flaminia

Background: The dexamethasone suppression test (DST) is among essential tests for hypercortisolism diagnosis. Due to high sensitivity and specificity, liquid chromatography-tandem mass spectrometry (LC-MS/MS) is replacing obsolete immunoassays (IA) for steroid measurement. However, exhaustive data about IA and LC-MS/MS concordance in the frame of DST are still not available.Aim: To compare cortisol measurements by two routine IAs and LC-MS/MS in basal (F...

ea0090p714 | Reproductive and Developmental Endocrinology | ECE2023

Newly diagnosed diabetes in Turner syndrome: what is the role of incretins?

Cecchetti Carolina , Dionese Paola , Belardinelli Elisabetta , Rotolo Laura , Solmi: Beatrice , Fanelli Flaminia , Pagotto Uberto , Gambineri Alessandra

Introduction: Diabetes mellitus (DM) develops early in Turner syndrome (TS) and appears not related to common risk factors. The precise mechanism of its development is still a matter of debate: a defective insulin response seems to be involved, but the role of incretins is still undefined.Objective: To evaluate the implication of incretin release in the early stages of DM development in TS. Materials and Methods: 153 Turner patient...

ea0081p273 | Adrenal and Cardiovascular Endocrinology | ECE2022

Salivary profiles of cortisol and cortisone in patients with primary adrenal insufficiency under replacement therapy: a pilot study

Tucci Lorenzo , Vicennati Valentina , Magagnoli Matteo , Colombin Giacomo , Coscia Kimberly , Rotolo Laura , Fanelli Flaminia , Pagotto Uberto , Di Dalmazi Guido

Background: Evaluation of steroid replacement therapy (SRT) in adrenal insufficiency (AI) is challenging for the lack of reliable parameters. Measurement of salivary cortisol and cortisone emerged as a non-invasive tool for AI management, however poorly investigated. Aim: To analyse the cortisol and cortisone circadian rhythm in normal controls (NC) and patients with primary AI (PAI) under different SRTs, and to identify useful biomarkers. <p class="...

ea0090rc4.2 | Rapid Communications 4: Reproductive and Developmental Endocrinology | ECE2023

Evolution of cardiovascular risk markers in polycystic ovary syndrome: Results from a long-term monocentric cohort study

Cecchetti Carolina , Pandurevic Srdjan , Dionese Paola , Belardinelli Elisabetta , Rotolo Laura , Fanelli Flaminia , Bergamaschi Luca , Pizzi Carmine , Pagotto Uberto , Gambineri Alessandra

Background: Many questions concerning polycystic ovary syndrome (PCOS) remain unsolved, such as the long term evolution of cardiovascular (CV) risk markers and the risk for CV events.Methods: A total of 119 PCOS patients diagnosed in 2009 by NIH criteria at our Unit were evaluated at baseline for cardiovascular risk markers (hypertension, diabetes mellitus-DM, dyslipidaemia, obesity, carotid intima media thickness-cIMT, and epicardial fat thickness-EFT) ...

ea0090p462 | Reproductive and Developmental Endocrinology | ECE2023

Remission of ovarian hyperandrogenism in two post-menopausal women treated with GnRH analogue

Dionese Paola , Rotolo Laura , Bongiorno Claudio , Cecchetti Carolina , Starace Michela , Bruni Francesca , Pagotto Uberto , Gambineri Alessandra , Pelusi Carla

Background and aim: Ovarian hyperandrogenism is a known cause of post-menopausal hirsutism and virilisation, more frequently of a benign nature (e.g. ovarian hyperthecosis, Leydig cell hyperplasia). Bilateral salpingo-oophorectomy delivers both definitive diagnostic and therapeutic results. However, after excluding the presence of a suspicious ovarian mass, the use of GnRH analogues (GnRH-a) offers a valuable therapeutic alternative with cases reporting a sustained response in...

ea0093oc36 | Oral communication 5: Reproductive Endocrinology | EYES2023

Evolution of cardiovascular risk markers in polycystic ovary syndrome: Results from a long-term monocentric cohort study

Cecchetti Carolina , Pandurevic Srdjan , Dionese Paola , Belardinelli Elisabetta , Rotolo Laura , Fanelli Flaminia , Bergamaschi Luca , Pizzi Carmine , Pagotto Uberto , Gambineri Alessandra

Background: Many questions concerning polycystic ovary syndrome (PCOS) remain unsolved, such as the long-term evolution of cardiovascular (CV) risk markers and the risk for CV events.Methods: A total of 119 PCOS patients diagnosed in 2009 by NIH criteria at our Unit were evaluated at baseline for cardiovascular risk markers (hypertension, diabetes mellitus-DM, dyslipidaemia, obesity, carotid intima media thickness-cIMT, and epicardial fat thickness-EFT) ...

ea0090p559 | Adrenal and Cardiovascular Endocrinology | ECE2023

Anxiety, depression, quality of life and sleep: new insights in adrenal insufficiency care through salivary cortisol and cortisone diurnal rhythm measurement

Tucci Lorenzo , Vicennati Valentina , Bissi Valentina , Galante Greta , Colombin Giacomo , Coscia Kimberly , Improta Ilaria , Rotolo Laura , Fanelli Flaminia , Pagotto Uberto , Di Dalmazi Guido

Background: Adrenal insufficiency patient (AIP) care is mostly based on symptoms or clinical signs of inadequate glucocorticoid replacement treatment (GRT). Salivary cortisol (F) and cortisone (E) recently emerged as new tools for AIP management, although poorly employed in clinical practice.Aim: To assess associations between salivary glucocorticoid measures and life quality, anxiety depressive symptoms, sleep quality in AIP.Metho...